{"id":"https://openalex.org/W6982722","doi":null,"title":"Monoclonal antibodies in human cancer.","display_name":"Monoclonal antibodies in human cancer.","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W6982722","mag":"6982722","pmid":"https://pubmed.ncbi.nlm.nih.gov/14988743"},"language":"en","primary_location":{"id":"pmid:14988743","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14988743","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of today (Barcelona, Spain : 1998)","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W6982722"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069881022","display_name":"H\u00e5kan Mellstedt","orcid":"https://orcid.org/0000-0001-6756-0609","observed_orcids":["https://orcid.org/0000-0001-6756-0609"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"H Mellstedt","raw_affiliation_strings":["Department of Oncology and Hematology, Karolinska Cancer Center, Karolinska Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Karolinska Cancer Center, Karolinska Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5069881022"],"corresponding_institution_ids":["https://openalex.org/I1335113835"],"apc_list":null,"apc_paid":null,"fwci":2.595,"has_fulltext":false,"cited_by_count":84,"citation_normalized_percentile":{"value":0.89977311,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"39 Suppl C","issue":null,"first_page":"1","last_page":"16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8100000023841858},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9869999885559082},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.996999979019165},{"id":"https://openalex.org/keywords/idiotype-network","display_name":"idiotypic network","score":0.7820000052452087},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8460000157356262},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9480000138282776},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9779999852180481},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.703000009059906},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.7620000243186951},{"id":"https://openalex.org/keywords/anti-cd52-antibody","display_name":"anti-CD52 antibody","score":0.9120000004768372},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.8460000157356262},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7630000114440918},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.6679999828338623},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.7990000247955322},{"id":"https://openalex.org/keywords/renal-carcinoma","display_name":"renal carcinoma","score":0.8669999837875366},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.597000002861023},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8179881572723389},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8157482147216797},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5277534127235413},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5146301984786987},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.4966431260108948},{"id":"https://openalex.org/C2778384904","wikidata":"https://www.wikidata.org/wiki/Q21108353","display_name":"CD52","level":4,"score":0.4957521855831146},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.48730170726776123},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4781254827976227},{"id":"https://openalex.org/C2777607594","wikidata":"https://www.wikidata.org/wiki/Q389496","display_name":"Obinutuzumab","level":4,"score":0.4753023087978363},{"id":"https://openalex.org/C2777843201","wikidata":"https://www.wikidata.org/wiki/Q17163357","display_name":"Monoclonal antibody therapy","level":4,"score":0.4549103379249573}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:14988743","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14988743","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of today (Barcelona, Spain : 1998)","raw_type":"Journal Article"},{"id":"mag:6982722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14988743","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W2035218537","https://openalex.org/W2028218699","https://openalex.org/W2032475605","https://openalex.org/W2110681946","https://openalex.org/W1970119940","https://openalex.org/W1968625856","https://openalex.org/W2030875360"],"related_works":["https://openalex.org/W7097126863","https://openalex.org/W2322377311","https://openalex.org/W2915219448","https://openalex.org/W2072922980","https://openalex.org/W2408879624","https://openalex.org/W2415136187","https://openalex.org/W2412113210","https://openalex.org/W2164484724","https://openalex.org/W2021812388","https://openalex.org/W2009673033"],"abstract_inverted_index":{"Mouse,":[0],"chimeric,":[1],"humanized":[2],"and":[3,80,157,161,216,248],"human":[4,15],"monoclonal":[5],"antibodies":[6,18,85,97,224,269,289],"(MABs)":[7],"are":[8,122,171,221],"all":[9],"in":[10,92,125,149,159,174,183,189,198,211,225,242,246,253,261,272,276,292],"use":[11,294],"for":[12,138,201,230],"treatment":[13,185],"of":[14,23,29,47,57,73,96,128,141,186,228,280],"cancer.":[16],"Unconjugated":[17],"have":[19,146],"a":[20,181],"complex":[21],"mechanism":[22],"action,":[24],"dependent":[25],"on":[26],"the":[27,30,36,58,110,126,129,134,139,184,277,296],"nature":[28],"target":[31],"structure.":[32],"Antibodies":[33,64],"can":[34,98],"activate":[35,109],"immune":[37,61,111],"system":[38],"(antibody-dependent":[39],"cellular":[40],"cytotoxicity":[41,44],"[ADCC],":[42],"complement-dependent":[43],"[CDC],":[45],"induction":[46],"tumor":[48],"immunity":[49],"[idiotype":[50],"network]).":[51],"ADCC":[52],"appears":[53],"to":[54],"be":[55,99,118,291],"one":[56],"most":[59,84],"important":[60],"effector":[62],"functions.":[63],"may":[65,117],"also":[66,172,197],"induce":[67],"apoptosis,":[68],"cell":[69,74,266],"cycle":[70],"arrest,":[71],"inhibition":[72],"proliferation":[75],"as":[76,78,217],"well":[77],"angiogenesis":[79],"metastatic":[81],"spread.":[82],"For":[83],"there":[86],"is":[87,180,196,284],"no":[88],"clear":[89],"dose-response":[90],"relationship":[91],"vivo.":[93],"The":[94,113],"effect":[95,116],"enhanced":[100],"by":[101,106,295],"combination":[102,150,175,190,243,273],"with":[103,151,176,191,244,274],"chemotherapy":[104,153,275],"and/or":[105],"agents":[107],"which":[108],"system.":[112],"best":[114],"therapeutic":[115],"obtained":[119],"if":[120],"MABs":[121,233],"used":[123],"early":[124],"course":[127],"disease.":[130],"Rituximab":[131],"(anti-CD20)":[132],"was":[133],"first":[135],"registered":[136],"MAB":[137],"therapy":[140],"follicular":[142,160],"lymphoma.":[143],"Impressive":[144],"results":[145,170,209],"been":[147],"seen":[148,173],"CHOP":[152],"(cyclophosphamide,":[154],"doxorubicin,":[155],"vincristine":[156],"prednisone)":[158],"high-grade":[162],"lymphomas.":[163],"In":[164],"other":[165,223],"non-Hodgkin's":[166],"lymphoma":[167],"subtypes,":[168],"promising":[169],"chemotherapy.":[177],"Trastuzumab":[178],"(anti-Her2)":[179],"breakthrough":[182],"breast":[187],"cancer":[188],"chemotherapeutic":[192],"agents.":[193],"This":[194],"antibody":[195],"clinical":[199,293],"testing":[200,229],"adjuvant":[202,278],"treatment.":[203],"Alemtuzumab":[204],"(anti-CD52)":[205],"has":[206],"shown":[207],"impressive":[208],"both":[210],"refractory":[212],"chronic":[213],"lymphocytic":[214],"leukemia":[215],"up-front":[218],"therapy.":[219],"There":[220],"many":[222],"late":[226],"stages":[227],"registration.":[231],"Interesting":[232],"include":[234],"cetuximab":[235],"(anti-epidermal":[236],"growth":[237,259],"factor":[238],"receptor":[239],"[EGFR]),":[240],"especially":[241],"radiotherapy":[245],"head":[247],"neck":[249],"cancer;":[250],"ABX-EGF":[251],"(anti-EGFR)":[252],"renal":[254],"carcinoma;":[255],"bevacizumab":[256],"(anti-vascular":[257],"endothelial":[258],"factor)":[260],"several":[262],"solid":[263],"tumors.":[264],"Antiepithelial":[265],"adhesion":[267],"molecule":[268],"show":[270],"promise":[271],"setting":[279],"colorectal":[281],"carcinoma.":[282],"It":[283],"estimated":[285],"that":[286],"about":[287],"20":[288],"will":[290],"year":[297],"2010.":[298]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
